Tariffs Increase Small Business Insurance Premiums
Table of Contents
Expert Context: Dr. Jennifer Chen
This analysis details the potential impact of President trump’s tariffs, especially those on pharmaceutical imports, on health insurance premiums, focusing on the small group market. The core issue is that tariffs increase the cost of imported medical goods, especially prescription drugs, and this cost is being factored into insurance pricing before the full impact is even realized.
Key Findings
Tariff Implementation: The Trump governance indicated a phased implementation of tariffs on pharmaceutical imports, starting with a “small tariff” and potentially reaching up to 250% over 12-18 months.
Proactive Premium Increases: Insurers are preemptively incorporating potential tariff-related cost increases into their proposed rates for the upcoming plan year, even in the absence of definitive policy guidance. This is a cautious approach to avoid underpricing.
Pharmaceuticals’ Share of Claims: Pharmaceuticals typically account for 16-22% of total health claims (after rebates).
Market Segment variation: Pharmaceuticals represent a slightly larger share of health claims in the small group market (19.2%) compared to the individual (18.2%) and large group (17.9%) markets. Explicit Tariff Citations: In ACA-compliant small group market rate filings, 25% (22 out of 88) explicitly mentioned tariffs as a reason for higher premium increases.others likely factored in the effects without direct mention.
Impact on Premiums: Some insurers in the individual market have included upward adjustments of approximately 3% in response to anticipated increases in drug costs tied to tariffs. Drug Focus: Tariffs are expected to particularly impact the cost of brand-name and specialty drugs lacking generic alternatives.
| Market Segment | Pharmaceutical Share of Claims (%) |
| :————- | :——————————— |
| Small Group | 19.2 |
| Individual | 18.2 |
| Large Group | 17.9 |
- Tariffs Increase Drug Costs: Tariffs directly increase the price of imported pharmaceuticals.
- Insurers Anticipate Costs: Insurers must estimate future medical costs when setting premiums.
- Preemptive Rate adjustments: Due to policy uncertainty, insurers proactively build potential tariff-related cost increases into their proposed rates.
- Higher Premiums: This results in higher premiums for consumers, even before the tariff’s full impact on drug prices is felt.
- Limited Alternatives: The effect is amplified for brand-name and specialty drugs with few or no generic alternatives.
Implications
These tariffs create uncertainty in the health insurance market and contribute to rising premiums. The proactive approach taken by insurers, while prudent, means that consumers may experience premium increases based on potential* cost increases, rather than actual ones. This is particularly concerning in markets with tight margins.
– drjenniferchen